{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T04:08:19Z","timestamp":1744862899656,"version":"3.40.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,16]]},"DOI":"10.7759\/cureus.82355","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T10:06:25Z","timestamp":1744797985000},"source":"Crossref","is-referenced-by-count":0,"title":["Role of Adipokines in the Development of Metabolic Syndrome in Patients With Polycystic Ovary Syndrome"],"prefix":"10.7759","author":[{"given":"Chaitali","family":"Maitra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjun","family":"Maitra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/sui021","article-title":"Introduction to the metabolic syndrome","volume":"7","author":"Alberti G","year":"2005","unstructured":"Alberti G. Introduction to the metabolic syndrome. Eur Heart J Suppl. 2005, 7:3-5. 10.1093\/eurheartj\/sui021","journal-title":"Eur Heart J Suppl"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement","volume":"112","author":"Grundy SM","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, et al.. Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005, 112:2735-52. 10.1161\/CIRCULATIONAHA.105.169404","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze T","year":"2005","unstructured":"Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005, 90:1929-35. 10.1210\/jc.2004-1045","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2018.02.031","article-title":"Metabolic risk assessment of Indian women with polycystic ovarian syndrome in relation to four Rotterdam criteria based phenotypes","volume":"224","author":"Tripathy P","year":"2018","unstructured":"Tripathy P, Sahu A, Sahu M, Nagy A. Metabolic risk assessment of Indian women with polycystic ovarian syndrome in relation to four Rotterdam criteria based phenotypes. Eur J Obstet Gynecol Reprod Biol. 2018, 224:60-5. 10.1016\/j.ejogrb.2018.02.031","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12762","article-title":"Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression","volume":"20","author":"Lim SS","year":"2019","unstructured":"Lim SS, Kakoly NS, Tan JW, et al.. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Obes Rev. 2019, 20:339-52. 10.1111\/obr.12762","journal-title":"Obes Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(03)00104-5","article-title":"Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome","volume":"52","author":"Glueck CJ","year":"2003","unstructured":"Glueck CJ, Papanna R, Wang P, Goldenberg N. Sieve-Smith L. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism. 2003, 52:908-15. 10.1016\/S0026-0495(03)00104-5","journal-title":"Metabolism"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2006.04.013","article-title":"Metabolic syndrome in women with polycystic ovary syndrome","volume":"86 Suppl 1","author":"Essah PA","year":"2006","unstructured":"Essah PA, Nestler JE. Metabolic syndrome in women with polycystic ovary syndrome. Fertil Steril. 2006, 86 Suppl 1:S18-9. 10.1016\/j.fertnstert.2006.04.013","journal-title":"Fertil Steril"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.22074\/ijfs.2015.4607","article-title":"Metabolic syndrome in patients with polycystic ovary syndrome in Iran","volume":"9","author":"Zahiri Z","year":"2016","unstructured":"Zahiri Z, Sharami SH, Milani F, Mohammadi F, Kazemnejad E, Ebrahimi H, Dalil Heirati SF. Metabolic syndrome in patients with polycystic ovary syndrome in Iran. Int J Fertil Steril. 2016, 9:490-6. 10.22074\/ijfs.2015.4607","journal-title":"Int J Fertil Steril"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.03.081","article-title":"Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome","volume":"89","author":"Soares EM","year":"2008","unstructured":"Soares EM, Azevedo GD, Gadelha RG, Lemos TM, Maranh\u00e3o TM. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome. Fertil Steril. 2008, 89:649-55. 10.1016\/j.fertnstert.2007.03.081","journal-title":"Fertil Steril"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/den090","article-title":"Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome","volume":"23","author":"Cheung LP","year":"2008","unstructured":"Cheung LP, Ma RC, Lam PM, et al.. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome. Hum Reprod. 2008, 23:1431-8. 10.1093\/humrep\/den090","journal-title":"Hum Reprod"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/0974-1208.97791","article-title":"Prevalence of metabolic syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in south India","volume":"5","author":"Mandrelle K","year":"2012","unstructured":"Mandrelle K, Kamath MS, Bondu DJ, Chandy A, Aleyamma T, George K. Prevalence of metabolic syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in south India. J Hum Reprod Sci. 2012, 5:26-31. 10.4103\/0974-1208.97791","journal-title":"J Hum Reprod Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2017.04.007","article-title":"Racial and ethnic differences in the prevalence of metabolic\u00a0syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a\u00a0regional cross-sectional study","volume":"217","author":"Chan JL","year":"2017","unstructured":"Chan JL, Kar S, Vanky E, et al.. Racial and ethnic differences in the prevalence of metabolic\u00a0syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a\u00a0regional cross-sectional study. Am J Obstet Gynecol. 2017, 217:189.e1-8. 10.1016\/j.ajog.2017.04.007","journal-title":"Am J Obstet Gynecol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/del407","article-title":"Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis","volume":"22","author":"Nader S","year":"2007","unstructured":"Nader S, Diamanti-Kandarakis E. Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis. Hum Reprod. 2007, 22:317-22. 10.1093\/humrep\/del407","journal-title":"Hum Reprod"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.19.2081","article-title":"Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women","volume":"166","author":"Alvarez-Blasco F","year":"2006","unstructured":"Alvarez-Blasco F, Botella-Carretero JI, San Mill\u00e1n JL, Escobar-Morreale HF. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch Intern Med. 2006, 166:2081-6. 10.1001\/archinte.166.19.2081","journal-title":"Arch Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1834","article-title":"Impact of obesity on the risk for polycystic ovary syndrome","volume":"93","author":"Yildiz BO","year":"2008","unstructured":"Yildiz BO, Knochenhauer ES, Azziz R. Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab. 2008, 93:162-8. 10.1210\/jc.2007-1834","journal-title":"J Clin Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/nu5072708","article-title":"Obesity and dyslipidemia in South Asians","volume":"5","author":"Misra A","year":"2013","unstructured":"Misra A, Shrivastava U. Obesity and dyslipidemia in South Asians. Nutrients. 2013, 5:2708-33. 10.3390\/nu5072708","journal-title":"Nutrients"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-011-0189-8","article-title":"Adipose tissue dysfunction in polycystic ovary syndrome","volume":"11","author":"Villa J","year":"2011","unstructured":"Villa J, Pratley RE. Adipose tissue dysfunction in polycystic ovary syndrome. Curr Diab Rep. 2011, 11:179-84. 10.1007\/s11892-011-0189-8","journal-title":"Curr Diab Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00333.2007","article-title":"Secretion of neuropeptide Y in human adipose tissue and its role in maintenance of adipose tissue mass","volume":"293","author":"Kos K","year":"2007","unstructured":"Kos K, Harte AL, James S, Snead DR, O'Hare JP, McTernan PG, Kumar S. Secretion of neuropeptide Y in human adipose tissue and its role in maintenance of adipose tissue mass. Am J Physiol Endocrinol Metab. 2007, 293:E1335-40. 10.1152\/ajpendo.00333.2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2010.01.009","article-title":"Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity","volume":"21","author":"Unger RH","year":"2010","unstructured":"Unger RH, Scherer PE. Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Trends Endocrinol Metab. 2010, 21:345-52. 10.1016\/j.tem.2010.01.009","journal-title":"Trends Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/147323000903700616","article-title":"The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes","volume":"37","author":"Lee JM","year":"2009","unstructured":"Lee JM, Kim SR, Yoo SJ, Hong OK, Son HS, Chang SA. The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes. J Int Med Res. 2009, 37:1803-12. 10.1177\/147323000903700616","journal-title":"J Int Med Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i11.1330","article-title":"Anti-inflammatory pathways and alcoholic liver disease: role of an adiponectin\/interleukin-10\/heme oxygenase-1 pathway","volume":"16","author":"Mandal P","year":"2010","unstructured":"Mandal P, Pritchard MT, Nagy LE. Anti-inflammatory pathways and alcoholic liver disease: role of an adiponectin\/interleukin-10\/heme oxygenase-1 pathway. World J Gastroenterol. 2010, 16:1330-6. 10.3748\/wjg.v16.i11.1330","journal-title":"World J Gastroenterol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0801244","article-title":"Genomic structure and mutations in adipose-specific gene, adiponectin","volume":"24","author":"Takahashi M","year":"2000","unstructured":"Takahashi M, Arita Y, Yamagata K, et al.. Genomic structure and mutations in adipose-specific gene, adiponectin. Int J Obes Relat Metab Disord. 2000, 24:861-8. 10.1038\/sj.ijo.0801244","journal-title":"Int J Obes Relat Metab Disord"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0173-z","article-title":"Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin","volume":"49","author":"Curat CA","year":"2006","unstructured":"Curat CA, Wegner V, Sengen\u00e8s C, Miranville A, Tonus C, Busse R, Bouloumi\u00e9 A. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia. 2006, 49:744-7. 10.1007\/s00125-006-0173-z","journal-title":"Diabetologia"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4161\/isl.3.5.16427","article-title":"Diabetes mellitus is associated with an increased expression of resistin in human pancreatic islet cells","volume":"3","author":"Al-Salam S","year":"2011","unstructured":"Al-Salam S, Rashed H, Adeghate E. Diabetes mellitus is associated with an increased expression of resistin in human pancreatic islet cells. Islets. 2011, 3:246-9. 10.4161\/isl.3.5.16427","journal-title":"Islets"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2007.11.010","article-title":"Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults","volume":"57","author":"Aquilante CL","year":"2008","unstructured":"Aquilante CL, Kosmiski LA, Knutsen SD, Zineh I. Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults. Metabolism. 2008, 57:494-501. 10.1016\/j.metabol.2007.11.010","journal-title":"Metabolism"},{"key":"ref26","article-title":"A comparison of the new international diabetes federation definition of metabolic syndrome to WHO and NCEP definitions in Chinese, European and South Asian origin adults","volume":"17","author":"Unwin N","year":"2007","unstructured":"Unwin N, Bhopal R, Hayes L, White M, Patel S, Ragoobirsingh D, Alberti G. A comparison of the new international diabetes federation definition of metabolic syndrome to WHO and NCEP definitions in Chinese, European and South Asian origin adults. Ethn Dis. 2007, 17:522-8.","journal-title":"Ethn Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann DA","year":"2006","unstructured":"Ehrmann DA, Liljenquist DR, Kasza K, Azziz R, Legro RS, Ghazzi MN. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2006, 91:48-53. 10.1210\/jc.2005-1329","journal-title":"J Clin Endocrinol Metab"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6102085","article-title":"Waist circumference coupled with either HDL-C or TG can be used as a diagnostic marker for metabolic syndrome in Chinese women with polycystic ovary syndrome","volume":"2018","author":"Sun Y","year":"2018","unstructured":"Sun Y, Wang W, Shen Q, Du S, Guo Y, He F, Zhang W. Waist circumference coupled with either HDL-C or TG can be used as a diagnostic marker for metabolic syndrome in Chinese women with polycystic ovary syndrome. Int J Endocrinol. 2018, 2018:6102085. 10.1155\/2018\/6102085","journal-title":"Int J Endocrinol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/oby.21033","article-title":"The role of androgens in metabolism, obesity, and diabetes in males and females","volume":"23","author":"Navarro G","year":"2015","unstructured":"Navarro G, Allard C, Xu W, Mauvais-Jarvis F. The role of androgens in metabolism, obesity, and diabetes in males and females. Obesity (Silver Spring). 2015, 23:713-9. 10.1002\/oby.21033","journal-title":"Obesity (Silver Spring)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2021.2003326","article-title":"Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance","volume":"38","author":"Hern\u00e1ndez-Jim\u00e9nez JL","year":"2022","unstructured":"Hern\u00e1ndez-Jim\u00e9nez JL, Barrera D, Espinoza-Sim\u00f3n E, et al.. Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance. Gynecol Endocrinol. 2022, 38:2-9. 10.1080\/09513590.2021.2003326","journal-title":"Gynecol Endocrinol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-015-3889-5","article-title":"Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria","volume":"293","author":"Jamil AS","year":"2016","unstructured":"Jamil AS, Alalaf SK, Al-Tawil NG, Al-Shawaf T. Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria. Arch Gynecol Obstet. 2016, 293:447-56. 10.1007\/s00404-015-3889-5","journal-title":"Arch Gynecol Obstet"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/den263","article-title":"Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome","volume":"23","author":"Cussons AJ","year":"2008","unstructured":"Cussons AJ, Watts GF, Burke V, Shaw JE, Zimmet PZ, Stuckey BG. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome. Hum Reprod. 2008, 23:2352-8. 10.1093\/humrep\/den263","journal-title":"Hum Reprod"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/15.1.24","article-title":"Women with polycystic ovary syndrome gain regular menstrual cycles when ageing","volume":"15","author":"Elting MW","year":"2000","unstructured":"Elting MW, Korsen TJ, Rekers-Mombarg LT, Schoemaker J. Women with polycystic ovary syndrome gain regular menstrual cycles when ageing. Hum Reprod. 2000, 15:24-8. 10.1093\/humrep\/15.1.24","journal-title":"Hum Reprod"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C200251200","article-title":"Disruption of adiponectin causes insulin resistance and neointimal formation","volume":"277","author":"Kubota N","year":"2002","unstructured":"Kubota N, Terauchi Y, Yamauchi T, et al.. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem. 2002, 277:25863-6. 10.1074\/jbc.C200251200","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2015.1126708","article-title":"Serum adiponectin is independently associated with the metabolic syndrome in Hong Kong, Chinese women with polycystic ovary syndrome","volume":"32","author":"Ko JK","year":"2016","unstructured":"Ko JK, Li HW, Lam KS, et al.. Serum adiponectin is independently associated with the metabolic syndrome in Hong Kong, Chinese women with polycystic ovary syndrome. Gynecol Endocrinol. 2016, 32:390-4. 10.3109\/09513590.2015.1126708","journal-title":"Gynecol Endocrinol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2765","article-title":"Circulating adiponectin is associated with obesity and serum lipids in West Africans","volume":"95","author":"Meilleur KG","year":"2010","unstructured":"Meilleur KG, Doumatey A, Huang H, et al.. Circulating adiponectin is associated with obesity and serum lipids in West Africans. J Clin Endocrinol Metab. 2010, 95:3517-21. 10.1210\/jc.2009-2765","journal-title":"J Clin Endocrinol Metab"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2009.05.010","article-title":"Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment","volume":"19","author":"Garruti G","year":"2009","unstructured":"Garruti G, Depalo R, Vita MG, Lorusso F, Giampetruzzi F, Damato AB, Giorgino F. Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment. Reprod Biomed Online. 2009, 19:552-63. 10.1016\/j.rbmo.2009.05.010","journal-title":"Reprod Biomed Online"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.845165","article-title":"Elevated serum leptin levels as a predictive marker for polycystic ovary syndrome","volume":"13","author":"Peng Y","year":"2022","unstructured":"Peng Y, Yang H, Song J, et al.. Elevated serum leptin levels as a predictive marker for polycystic ovary syndrome. Front Endocrinol (Lausanne). 2022, 13:845165. 10.3389\/fendo.2022.845165","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2002.1","article-title":"Resistin gene expression in human adipocytes is not related to insulin resistance","volume":"10","author":"Janke J","year":"2002","unstructured":"Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM. Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res. 2002, 10:1-5. 10.1038\/oby.2002.1","journal-title":"Obes Res"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.7754\/clin.lab.2015.150533","article-title":"Relationship between serum resistin level of Xinjiang Uygur and Han subjects with metabolic syndrome","volume":"61","author":"Han J","year":"2015","unstructured":"Han J, Yakup K, Yuan Q, et al.. Relationship between serum resistin level of Xinjiang Uygur and Han subjects with metabolic syndrome. Clin Lab. 2015, 61:1941-6. 10.7754\/clin.lab.2015.150533","journal-title":"Clin Lab"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(02)07281-1","article-title":"Resistin, central obesity, and type 2 diabetes","volume":"359","author":"McTernan CL","year":"2002","unstructured":"McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S. Resistin, central obesity, and type 2 diabetes. Lancet. 2002, 359:46-7. 10.1016\/s0140-6736(02)07281-1","journal-title":"Lancet"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1089\/gtmb.2012.0156","article-title":"Association between four resistin polymorphisms, obesity, and metabolic syndrome parameters in Tunisian volunteers","volume":"16","author":"Boumaiza I","year":"2012","unstructured":"Boumaiza I, Omezzine A, Rejeb J, et al.. Association between four resistin polymorphisms, obesity, and metabolic syndrome parameters in Tunisian volunteers. Genet Test Mol Biomarkers. 2012, 16:1356-62. 10.1089\/gtmb.2012.0156","journal-title":"Genet Test Mol Biomarkers"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2014.152","article-title":"Correlation of serum adiponectin and adiponectin gene polymorphism with metabolic syndrome in Chinese adolescents","volume":"69","author":"Li P","year":"2015","unstructured":"Li P, Jiang R, Li L, Liu C, Yang F, Qiu Y. Correlation of serum adiponectin and adiponectin gene polymorphism with metabolic syndrome in Chinese adolescents. Eur J Clin Nutr. 2015, 69:62-7. 10.1038\/ejcn.2014.152","journal-title":"Eur J Clin Nutr"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1089\/gtmb.2011.0324","article-title":"Relationship between leptin G2548A and leptin receptor Q223R gene polymorphisms and obesity and metabolic syndrome risk in Tunisian volunteers","volume":"16","author":"Boumaiza I","year":"2012","unstructured":"Boumaiza I, Omezzine A, Rejeb J, et al.. Relationship between leptin G2548A and leptin receptor Q223R gene polymorphisms and obesity and metabolic syndrome risk in Tunisian volunteers. Genet Test Mol Biomarkers. 2012, 16:726-33. 10.1089\/gtmb.2011.0324","journal-title":"Genet Test Mol Biomarkers"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2008.04.146","article-title":"Globular adiponectin inhibits GnRH secretion from GT1-7 hypothalamic GnRH neurons by induction of hyperpolarization of membrane potential","volume":"371","author":"Wen JP","year":"2008","unstructured":"Wen JP, Lv WS, Yang J, et al.. Globular adiponectin inhibits GnRH secretion from GT1-7 hypothalamic GnRH neurons by induction of hyperpolarization of membrane potential. Biochem Biophys Res Commun. 2008, 371:756-61. 10.1016\/j.bbrc.2008.04.146","journal-title":"Biochem Biophys Res Commun"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080416","article-title":"Adiponectin and its receptors in the ovary: further evidence for a link between obesity and hyperandrogenism in polycystic ovary syndrome","volume":"8","author":"Comim FV","year":"2013","unstructured":"Comim FV, Hardy K, Franks S. Adiponectin and its receptors in the ovary: further evidence for a link between obesity and hyperandrogenism in polycystic ovary syndrome. PLoS One. 2013, 8:e80416. 10.1371\/journal.pone.0080416","journal-title":"PLoS One"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2152","article-title":"Resistin stimulation of 17alpha-hydroxylase activity in ovarian theca cells in vitro: relevance to polycystic ovary syndrome","volume":"90","author":"Munir I","year":"2005","unstructured":"Munir I, Yen HW, Baruth T, Tarkowski R, Azziz R, Magoffin DA, Jakimiuk AJ. Resistin stimulation of 17alpha-hydroxylase activity in ovarian theca cells in vitro: relevance to polycystic ovary syndrome. J Clin Endocrinol Metab. 2005, 90:4852-7. 10.1210\/jc.2004-2152","journal-title":"J Clin Endocrinol Metab"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1210\/endo.137.7.8770941","article-title":"Leptin is a metabolic signal to the reproductive system","volume":"137","author":"Barash IA","year":"1996","unstructured":"Barash IA, Cheung CC, Weigle DS, et al.. Leptin is a metabolic signal to the reproductive system. Endocrinology. 1996, 137:3144-7. 10.1210\/endo.137.7.8770941","journal-title":"Endocrinology"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(01)03010-2","article-title":"Leptin and reproduction: a review","volume":"77(3)","author":"Moschos S","year":"2002","unstructured":"Moschos S, Chan JL, Mantzoros C. Leptin and reproduction: a review. Fertil Steril. 2002, 77(3):433-44. 10.1016\/S0015-0282(01)03010-2","journal-title":"Fertil Steril"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1253\/circj.68.975","article-title":"Adiponectin as a biomarker of the metabolic syndrome","volume":"68","author":"Ryo M","year":"2004","unstructured":"Ryo M, Nakamura T, Kihara S, et al.. Adiponectin as a biomarker of the metabolic syndrome. Circ J. 2004, 68:975-81. 10.1253\/circj.68.975","journal-title":"Circ J"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.109.885525","article-title":"Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure","volume":"3","author":"Van Berendoncks AM","year":"2010","unstructured":"Van Berendoncks AM, Garnier A, Beckers P, et al.. Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure. Circ Heart Fail. 2010, 3:185-94. 10.1161\/CIRCHEARTFAILURE.109.885525","journal-title":"Circ Heart Fail"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2586","article-title":"Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women","volume":"101","author":"Dumesic DA","year":"2016","unstructured":"Dumesic DA, Akopians AL, Madrigal VK, et al.. Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women. J Clin Endocrinol Metab. 2016, 101:4178-88. 10.1210\/jc.2016-2586","journal-title":"J Clin Endocrinol Metab"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1186\/1476-511X-11-101","article-title":"Prediction of metabolic syndrome among postmenopausal Ghanaian women using obesity and atherogenic markers","volume":"11","author":"Arthur FK","year":"2012","unstructured":"Arthur FK, Adu-Frimpong M, Osei-Yeboah J, Mensah FO, Owusu L. Prediction of metabolic syndrome among postmenopausal Ghanaian women using obesity and atherogenic markers. Lipids Health Dis. 2012, 11:101. 10.1186\/1476-511X-11-101","journal-title":"Lipids Health Dis"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000001136","article-title":"Metabolic syndrome and its components in premenopausal and postmenopausal women: a comprehensive systematic review and meta-analysis on observational studies","volume":"25","author":"Hallajzadeh J","year":"2018","unstructured":"Hallajzadeh J, Khoramdad M, Izadi N, et al.. Metabolic syndrome and its components in premenopausal and postmenopausal women: a comprehensive systematic review and meta-analysis on observational studies. Menopause. 2018, 25:1155-64. 10.1097\/GME.0000000000001136","journal-title":"Menopause"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/315935-role-of-adipokines-in-the-development-of-metabolic-syndrome-in-patients-with-polycystic-ovary-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T10:06:26Z","timestamp":1744797986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/315935-role-of-adipokines-in-the-development-of-metabolic-syndrome-in-patients-with-polycystic-ovary-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":54,"URL":"https:\/\/doi.org\/10.7759\/cureus.82355","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,16]]}}}